BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valeriani E, Di Nisio M, Riva N, Cohen O, Garcia-Pagan JC, Magaz M, Porreca E, Ageno W. Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis. Blood 2021;137:1233-40. [PMID: 32911539 DOI: 10.1182/blood.2020006827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Riva N, Ageno W. Direct oral anticoagulants for unusual-site venous thromboembolism. Res Pract Thromb Haemost 2021;5:265-77. [PMID: 33733025 DOI: 10.1002/rth2.12480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Valeriani E, Di Nisio M, Riva N, Caiano LM, Porreca E, Bang SM, Beyer-Westendorf J, Sartori MT, Barillari G, Santoro R, Kamphuisen PW, Alatri A, Malato A, Vidili G, Oh D, Schulman S, Ageno W; International Registry on Splanchnic Vein Thrombosis (IRSVT) study group. Clinical history of cancer-associated splanchnic vein thrombosis. J Thromb Haemost 2021;19:983-91. [PMID: 33306241 DOI: 10.1111/jth.15214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kawata E, Siew DA, Payne JG, Louzada M, Kovacs MJ, Lazo-Langner A. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes. Thromb Res 2021;202:90-5. [PMID: 33798804 DOI: 10.1016/j.thromres.2021.03.018] [Reference Citation Analysis]
4 Samuelson Bannow BT. Treating SVT: more than just a "gut feeling". Blood 2021;137:1141. [PMID: 33661289 DOI: 10.1182/blood.2020008962] [Reference Citation Analysis]